A situational analysis of breast cancer early detection services in Trinidad and Tobago

go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.1002/ijc.29210 CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. doi:10.​1002/​ijc.​29210 CrossRefPubMed

go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. doi:10.3322/caac.21262 CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. doi:10.​3322/​caac.​21262 CrossRefPubMed

go back to reference DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A (2015) International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomark Prev 24(10):1495–1506. doi:10.1158/1055-9965.EPI-15-0535 CrossRef DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A (2015) International variation in female breast cancer incidence and mortality rates. Cancer Epidemiol Biomark Prev 24(10):1495–1506. doi:10.​1158/​1055-9965.​EPI-15-0535 CrossRef

go back to reference Institute NC SEER cancer statistics factsheets: female breast cancer. http://seer.cancer.gov/statfacts/html/breast.html. Accessed 9 Dec 2016 Institute NC SEER cancer statistics factsheets: female breast cancer. http://​seer.​cancer.​gov/​statfacts/​html/​breast.​html. Accessed 9 Dec 2016

go back to reference Hashemi SH, Karimi S, Mahboobi H (2014) Lifestyle changes for prevention of breast cancer. Electron Physician 6(3):894–905. doi:10.14661/2014.894-905 PubMedPubMedCentral Hashemi SH, Karimi S, Mahboobi H (2014) Lifestyle changes for prevention of breast cancer. Electron Physician 6(3):894–905. doi:10.​14661/​2014.​894-905 PubMedPubMedCentral

go back to reference Colditz G, Bohlke K (2014) Priorities for the primary prevention of breast cancer. CA 00:1–9. doi:10.3322/caac.21225 Colditz G, Bohlke K (2014) Priorities for the primary prevention of breast cancer. CA 00:1–9. doi:10.​3322/​caac.​21225

go back to reference Ga Colditz, Bohlke K (2015) Preventing breast cancer now by acting on what we already know. npj. Breast Cancer 19:19–22. doi:10.1038/npjbcancer.2015.9 Ga Colditz, Bohlke K (2015) Preventing breast cancer now by acting on what we already know. npj. Breast Cancer 19:19–22. doi:10.​1038/​npjbcancer.​2015.​9

go back to reference Hajian S, Vakilian K, Najabadi KM, Hosseini J, Mirzaei HR (2011) Effects of education based on the health belief model on screening behavior in high risk women for breast cancer, Tehran, Iran. Asian Pac J Cancer Prev 12(1):49–54PubMed Hajian S, Vakilian K, Najabadi KM, Hosseini J, Mirzaei HR (2011) Effects of education based on the health belief model on screening behavior in high risk women for breast cancer, Tehran, Iran. Asian Pac J Cancer Prev 12(1):49–54PubMed

go back to reference Ceber E, Turk M, Ciceklioglu M (2010) The effects of an educational program on knowledge of breast cancer, early detection practices and health beliefs of nurses and midwives. J Clin Nurs 19(15–16):2363–2371. doi:10.1111/j.1365-2702.2009.03150.x CrossRefPubMed Ceber E, Turk M, Ciceklioglu M (2010) The effects of an educational program on knowledge of breast cancer, early detection practices and health beliefs of nurses and midwives. J Clin Nurs 19(15–16):2363–2371. doi:10.​1111/​j.​1365-2702.​2009.​03150.​x CrossRefPubMed

go back to reference Schopper D, de Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 45(11):1916–1923. doi:10.1016/j.ejca.2009.03.022 CrossRefPubMed Schopper D, de Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 45(11):1916–1923. doi:10.​1016/​j.​ejca.​2009.​03.​022 CrossRefPubMed

go back to reference Burton R, Bell R (2013) The global challenge of reducing breast cancer mortality. Oncologist 18(11):1200–1202. doi:10.1634/theoncologist.2013-0315 CrossRefPubMedPubMedCentral Burton R, Bell R (2013) The global challenge of reducing breast cancer mortality. Oncologist 18(11):1200–1202. doi:10.​1634/​theoncologist.​2013-0315 CrossRefPubMedPubMedCentral

go back to reference Jatoi I, Miller AB (2003) Why is breast-cancer mortality declining? Lancet Oncol 4(4):251–254CrossRefPubMed Jatoi I, Miller AB (2003) Why is breast-cancer mortality declining? Lancet Oncol 4(4):251–254CrossRefPubMed

go back to reference Luciani S, Cabanes A, Prieto-Lara E, Gawryszewski V (2013) Cervical and female breast cancers in the Americas: current situation and opportunities for action. Bull World Health Organ 91(9):640–649. doi:10.2471/BLT.12.116699 CrossRefPubMedPubMedCentral Luciani S, Cabanes A, Prieto-Lara E, Gawryszewski V (2013) Cervical and female breast cancers in the Americas: current situation and opportunities for action. Bull World Health Organ 91(9):640–649. doi:10.​2471/​BLT.​12.​116699 CrossRefPubMedPubMedCentral

go back to reference Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldana K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Duenas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabus R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernandez A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G (2013) Planning cancer control in Latin America and the Caribbean. Lancet Oncol 14(5):391–436. doi:10.1016/S1470-2045(13)70048-2 CrossRefPubMed Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldana K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Duenas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabus R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernandez A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G (2013) Planning cancer control in Latin America and the Caribbean. Lancet Oncol 14(5):391–436. doi:10.​1016/​S1470-2045(13)70048-2 CrossRefPubMed

go back to reference WHO (2012) Trinidad and Tobago Cancer Profile 2014.2010–2012 WHO (2012) Trinidad and Tobago Cancer Profile 2014.2010–2012

go back to reference Wa Warner, Morrison RL, Lee TY, Williams TM, Ramnarine S, Roach V, Slovacek S, Maharaj R, Bascombe N, Bondy ML, Ellis MJ, Toriola AT, Roach A, AaM Llanos (2015) Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and Tobago. Cancer Med. doi:10.1002/cam4.503 Wa Warner, Morrison RL, Lee TY, Williams TM, Ramnarine S, Roach V, Slovacek S, Maharaj R, Bascombe N, Bondy ML, Ellis MJ, Toriola AT, Roach A, AaM Llanos (2015) Associations among ancestry, geography and breast cancer incidence, mortality, and survival in Trinidad and Tobago. Cancer Med. doi:10.​1002/​cam4.​503

go back to reference Mungrue K, Ramdath J, Ali S, Cuffie WA, Dodough N, Gangar M, Mohammed L, Mungroo V, Ramsahai J, Shah M (2014) Challenges to the control of breast cancer in a small developing country. Breast Cancer 8:7–13. doi:10.4137/BCBCr.s12780 PubMedPubMedCentral Mungrue K, Ramdath J, Ali S, Cuffie WA, Dodough N, Gangar M, Mohammed L, Mungroo V, Ramsahai J, Shah M (2014) Challenges to the control of breast cancer in a small developing country. Breast Cancer 8:7–13. doi:10.​4137/​BCBCr.​s12780 PubMedPubMedCentral

go back to reference Naraynsingh V, Hariharan S, Dan D, Bhola S, Bhola S, Nagee K (2010) Trends in breast cancer mortality in Trinidad and Tobago-A 35-year study. Cancer Epidemiol. doi:10.1016/j.canep.2009.11.003 PubMed Naraynsingh V, Hariharan S, Dan D, Bhola S, Bhola S, Nagee K (2010) Trends in breast cancer mortality in Trinidad and Tobago-A 35-year study. Cancer Epidemiol. doi:10.​1016/​j.​canep.​2009.​11.​003 PubMed

go back to reference Taioli E, Attong-Rogers A, Layne P, Roach V, Ragin C (2010) Breast cancer survival in women of African descent living in the US and in the Caribbean: effect of place of birth. Breast Cancer Res Treat 122:515–520. doi:10.1007/s10549-009-0702-9 CrossRefPubMed Taioli E, Attong-Rogers A, Layne P, Roach V, Ragin C (2010) Breast cancer survival in women of African descent living in the US and in the Caribbean: effect of place of birth. Breast Cancer Res Treat 122:515–520. doi:10.​1007/​s10549-009-0702-9 CrossRefPubMed

go back to reference Camacho-Rivera M, Ragin C, Roach V, Kalwar T, Taioli E (2015) Breast cancer clinical characteristics and outcomes in Trinidad and Tobago. J Immigr Minor Health 17(3):765–772. doi:10.1007/s10903-013-9930-5 CrossRefPubMed Camacho-Rivera M, Ragin C, Roach V, Kalwar T, Taioli E (2015) Breast cancer clinical characteristics and outcomes in Trinidad and Tobago. J Immigr Minor Health 17(3):765–772. doi:10.​1007/​s10903-013-9930-5 CrossRefPubMed

go back to reference Murillo R, Diaz S, Perry F, Poveda C, Pineros M, Sanchez O, Buitrago L, Gamboa O, Lozano T, Yu H, Wang CY, Duggan C, Thomas DB, Anderson BO (2016) Increased breast cancer screening and downstaging in Colombian women: a randomized trial of opportunistic breast-screening. Int J Cancer 138(3):705–713. doi:10.1002/ijc.29801 CrossRefPubMed Murillo R, Diaz S, Perry F, Poveda C, Pineros M, Sanchez O, Buitrago L, Gamboa O, Lozano T, Yu H, Wang CY, Duggan C, Thomas DB, Anderson BO (2016) Increased breast cancer screening and downstaging in Colombian women: a randomized trial of opportunistic breast-screening. Int J Cancer 138(3):705–713. doi:10.​1002/​ijc.​29801 CrossRefPubMed

go back to reference Lui CY, Lam HS, Chan LK, Tam KF, Chan CM, Leung TY, Mak KL (2007) Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience. Hong Kong Med J 13(2):106–113PubMed Lui CY, Lam HS, Chan LK, Tam KF, Chan CM, Leung TY, Mak KL (2007) Opportunistic breast cancer screening in Hong Kong; a revisit of the Kwong Wah Hospital experience. Hong Kong Med J 13(2):106–113PubMed

go back to reference Teh YC, Tan GH, Taib NA, Rahmat K, Westerhout CJ, Fadzli F, See MH, Jamaris S, Yip CH (2015) Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system. BMC Cancer 15:405. doi:10.1186/s12885-015-1419-2 CrossRefPubMedPubMedCentral Teh YC, Tan GH, Taib NA, Rahmat K, Westerhout CJ, Fadzli F, See MH, Jamaris S, Yip CH (2015) Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system. BMC Cancer 15:405. doi:10.​1186/​s12885-015-1419-2 CrossRefPubMedPubMedCentral

go back to reference Hertl K, Primic-Zakelj M, Zgajnar J, Kocijancic I (2006) Performance of opportunistic breast cancer screening in Slovenia. Neoplasma 53(3):237–241PubMed Hertl K, Primic-Zakelj M, Zgajnar J, Kocijancic I (2006) Performance of opportunistic breast cancer screening in Slovenia. Neoplasma 53(3):237–241PubMed

go back to reference de Gelder R, Bulliard JL, de Wolf C, Fracheboud J, Draisma G, Schopper D, de Koning HJ (2009) Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. Eur J Cancer 45(1):127–138. doi:10.1016/j.ejca.2008.09.015 CrossRefPubMed de Gelder R, Bulliard JL, de Wolf C, Fracheboud J, Draisma G, Schopper D, de Koning HJ (2009) Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. Eur J Cancer 45(1):127–138. doi:10.​1016/​j.​ejca.​2008.​09.​015 CrossRefPubMed

go back to reference Welch HG, Prorok PC, O’Malley AJ, Kramer BS (2016) Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 375(15):1438–1447. doi:10.1056/NEJMoa1600249 CrossRefPubMed Welch HG, Prorok PC, O’Malley AJ, Kramer BS (2016) Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med 375(15):1438–1447. doi:10.​1056/​NEJMoa1600249 CrossRefPubMed

go back to reference Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E, Group EW (2012) Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19(Suppl 1):42–56. doi:10.1258/jms.2012.012082 CrossRefPubMed Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E, Group EW (2012) Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19(Suppl 1):42–56. doi:10.​1258/​jms.​2012.​012082 CrossRefPubMed

go back to reference Tosteson AN, Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, Wang Q, Lindfors K, Pisano ED (2014) Consequences of false-positive screening mammograms. JAMA Intern Med 174(6):954–961. doi:10.1001/jamainternmed.2014.981 CrossRefPubMedPubMedCentral Tosteson AN, Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, Wang Q, Lindfors K, Pisano ED (2014) Consequences of false-positive screening mammograms. JAMA Intern Med 174(6):954–961. doi:10.​1001/​jamainternmed.​2014.​981 CrossRefPubMedPubMedCentral

go back to reference Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Tornberg S, Project E, Euroscreen Working G, Van Hal G, Martens P, Majek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Pentek Z, Budai A, Madai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sanchez-Contador Escudero C, Zubizarreta Alberti R, Fernandez Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibanez Cabanell J, Wiege M, Ohlsson G, Tornberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E (2012) False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen 19(Suppl 1):57–66. doi:10.1258/jms.2012.012083 CrossRefPubMed Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, Giordano L, Frigerio A, Tornberg S, Project E, Euroscreen Working G, Van Hal G, Martens P, Majek O, Danes J, von Euler-Chelpin M, Aasmaa A, Anttila A, Becker N, Pentek Z, Budai A, Madai S, Fitzpatrick P, Mooney T, Zappa M, Ventura L, Scharpantgen A, Hofvind S, Seroczynski P, Morais A, Rodrigues V, Bento MJ, Gomes de Carvalho J, Natal C, Prieto M, Sanchez-Contador Escudero C, Zubizarreta Alberti R, Fernandez Llanes SB, Ascunce N, Ederra Sanza M, Sarriugarte Irigoien G, Salas Trejo D, Ibanez Cabanell J, Wiege M, Ohlsson G, Tornberg S, Korzeniewska M, de Wolf C, Fracheboud J, Patnick J, Lancucki L, Ducarroz S, Suonio E (2012) False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen 19(Suppl 1):57–66. doi:10.​1258/​jms.​2012.​012083 CrossRefPubMed

go back to reference Yaffe MJ, Mainprize JG (2011) Risk of radiation-induced breast cancer from mammographic screening. Radiology 258(1):98–105. doi:10.1148/radiol.10100655 CrossRefPubMed Yaffe MJ, Mainprize JG (2011) Risk of radiation-induced breast cancer from mammographic screening. Radiology 258(1):98–105. doi:10.​1148/​radiol.​10100655 CrossRefPubMed

go back to reference Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ, Hubbard RA (2016) Radiation-induced breast cancer incidence and mortality from digital mammography screening: a modeling study. Ann Intern Med 164(4):205–214. doi:10.7326/M15-1241 CrossRefPubMedPubMedCentral Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ, Hubbard RA (2016) Radiation-induced breast cancer incidence and mortality from digital mammography screening: a modeling study. Ann Intern Med 164(4):205–214. doi:10.​7326/​M15-1241 CrossRefPubMedPubMedCentral

go back to reference Gotzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev 1:CD001877. doi:10.1002/14651858.CD001877.pub4 Gotzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev 1:CD001877. doi:10.​1002/​14651858.​CD001877.​pub4

go back to reference Biller-Andorno N, Juni P (2014) Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 370(21):1965–1967. doi:10.1056/NEJMp1401875 CrossRefPubMed Biller-Andorno N, Juni P (2014) Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 370(21):1965–1967. doi:10.​1056/​NEJMp1401875 CrossRefPubMed

go back to reference Chantal Cases MDP, Eric Drahi, Sylvie Fainzang (2016) Concertation citoyenne et scientifique. Rapport du comité d’orientation Chantal Cases MDP, Eric Drahi, Sylvie Fainzang (2016) Concertation citoyenne et scientifique. Rapport du comité d’orientation

go back to reference Organization WH (2014) Position paper on mammography screening. WHO, Geneva, p 78 Organization WH (2014) Position paper on mammography screening. WHO, Geneva, p 78

go back to reference Shyyan R, Masood S, Badwe RA, Errico KM, Liberman L, Ozmen V, Stalsberg H, Vargas H, Vass L, Global Summit D, Pathology P (2006) Breast cancer in limited-resource countries: diagnosis and pathology. Breast J 12(Suppl 1):S27–S37. doi:10.1111/j.1075-122X.2006.00201.x CrossRefPubMed Shyyan R, Masood S, Badwe RA, Errico KM, Liberman L, Ozmen V, Stalsberg H, Vargas H, Vass L, Global Summit D, Pathology P (2006) Breast cancer in limited-resource countries: diagnosis and pathology. Breast J 12(Suppl 1):S27–S37. doi:10.​1111/​j.​1075-122X.​2006.​00201.​x CrossRefPubMed

go back to reference Health Statistics and Information Systems W (Revision July 2015) Service availability and readiness assessment (SARA): an annual monitoring system for service delivery. Reference Manual Health Statistics and Information Systems W (Revision July 2015) Service availability and readiness assessment (SARA): an annual monitoring system for service delivery. Reference Manual

go back to reference Organisation WH (2007) Cancer control: knowledge into action. WHO Guide for Effective Programmes, Early Detection Organisation WH (2007) Cancer control: knowledge into action. WHO Guide for Effective Programmes, Early Detection

go back to reference Trinidad & Tobago yellow pages http://tntyp.com/. 2016 Trinidad & Tobago yellow pages http://​tntyp.​com/​. 2016

go back to reference Office CS Trinidad and Tobago 2011 Population and Housing Census Demographic Report Office CS Trinidad and Tobago 2011 Population and Housing Census Demographic Report

go back to reference Elkin EB, Ishill NM, Snow JG, Panageas KS, Bach PB, Liberman L, Wang F, Schrag D (2010) Geographic access and the use of screening mammography. Med Care 48(4):349–356. doi:10.1097/MLR.0b013e3181ca3ecb CrossRefPubMedPubMedCentral Elkin EB, Ishill NM, Snow JG, Panageas KS, Bach PB, Liberman L, Wang F, Schrag D (2010) Geographic access and the use of screening mammography. Med Care 48(4):349–356. doi:10.​1097/​MLR.​0b013e3181ca3ecb​ CrossRefPubMedPubMedCentral

go back to reference Autier P, Ouakrim DA (2008) Determinants of the number of mammography units in 31 countries with significant mammography screening. Br J Cancer 99(7):1185–1190. doi:10.1038/sj.bjc.6604657 CrossRefPubMedPubMedCentral Autier P, Ouakrim DA (2008) Determinants of the number of mammography units in 31 countries with significant mammography screening. Br J Cancer 99(7):1185–1190. doi:10.​1038/​sj.​bjc.​6604657 CrossRefPubMedPubMedCentral

go back to reference Office USGA mammography: current nationwide capacity is adequate, but access problems may exist in certain locations. U.S. General Accounting Office, Washington, DC Office USGA mammography: current nationwide capacity is adequate, but access problems may exist in certain locations. U.S. General Accounting Office, Washington, DC

go back to reference Ranger B, Littrup PJ, Duric N, Chandiwala-Mody P, Li C, Schmidt S, Lupinacci J (2012) Breast ultrasound tomography versus MRI for clinical display of anatomy and tumor rendering: preliminary results. AJR Am J Roentgenol 198(1):233–239. doi:10.2214/AJR.11.6910 CrossRefPubMedPubMedCentral Ranger B, Littrup PJ, Duric N, Chandiwala-Mody P, Li C, Schmidt S, Lupinacci J (2012) Breast ultrasound tomography versus MRI for clinical display of anatomy and tumor rendering: preliminary results. AJR Am J Roentgenol 198(1):233–239. doi:10.​2214/​AJR.​11.​6910 CrossRefPubMedPubMedCentral

go back to reference Malur S, Wurdinger S, Moritz A, Michels W, Schneider A (2001) Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res 3(1):55–60CrossRefPubMed Malur S, Wurdinger S, Moritz A, Michels W, Schneider A (2001) Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res 3(1):55–60CrossRefPubMed

go back to reference Luparia A, Mariscotti G, Durando M, Ciatto S, Bosco D, Campanino PP, Castellano I, Sapino A, Gandini G (2013) Accuracy of tumour size assessment in the preoperative staging of breast cancer: comparison of digital mammography, tomosynthesis, ultrasound and MRI. Radiol Med 118(7):1119–1136. doi:10.1007/s11547-013-0941-z CrossRefPubMed Luparia A, Mariscotti G, Durando M, Ciatto S, Bosco D, Campanino PP, Castellano I, Sapino A, Gandini G (2013) Accuracy of tumour size assessment in the preoperative staging of breast cancer: comparison of digital mammography, tomosynthesis, ultrasound and MRI. Radiol Med 118(7):1119–1136. doi:10.​1007/​s11547-013-0941-z CrossRefPubMed

go back to reference Shin HJ, Kim HH, Ahn JH, Kim SB, Jung KH, Gong G, Son BH, Ahn SH (2011) Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy. Br J Radiol 84(1003):612–620. doi:10.1259/bjr/74430952 CrossRefPubMedPubMedCentral Shin HJ, Kim HH, Ahn JH, Kim SB, Jung KH, Gong G, Son BH, Ahn SH (2011) Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy. Br J Radiol 84(1003):612–620. doi:10.​1259/​bjr/​74430952 CrossRefPubMedPubMedCentral

go back to reference Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148(9):671–679CrossRefPubMed Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148(9):671–679CrossRefPubMed

go back to reference Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M, DeAngelis GA, Stomper P, Rosen EL, O’Loughlin M, Harms S, Bluemke DA, International Breast MRICWG (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103(9):1898–1905. doi:10.1002/cncr.20971 CrossRefPubMed Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M, DeAngelis GA, Stomper P, Rosen EL, O’Loughlin M, Harms S, Bluemke DA, International Breast MRICWG (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103(9):1898–1905. doi:10.​1002/​cncr.​20971 CrossRefPubMed

go back to reference Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28(3):509–518. doi:10.1200/JCO.2009.23.1274 CrossRefPubMed Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28(3):509–518. doi:10.​1200/​JCO.​2009.​23.​1274 CrossRefPubMed

go back to reference Early Breast Cancer Trialists’ Collaborative G, Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J, Goldhirsch A, Gray R, Peto R, Pritchard KI, Wood WC (2008) Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 371(9606):29–40. doi:10.1016/S0140-6736(08)60069-0 CrossRef Early Breast Cancer Trialists’ Collaborative G, Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J, Goldhirsch A, Gray R, Peto R, Pritchard KI, Wood WC (2008) Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 371(9606):29–40. doi:10.​1016/​S0140-6736(08)60069-0 CrossRef

go back to reference Early Breast Cancer Trialists’ Collaborative G (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717. doi:10.1016/S0140-6736(05)66544-0 CrossRef Early Breast Cancer Trialists’ Collaborative G (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717. doi:10.​1016/​S0140-6736(05)66544-0 CrossRef

go back to reference Early Breast Cancer Trialists’ Collaborative G, Coleman R, Powles T, Paterson A, Gnant M, Anderson S, Diel I, Gralow J, von Minckwitz G, Moebus V, Bergh J, Pritchard KI, Bliss J, Cameron D, Evans V, Pan H, Peto R, Bradley R, Gray R (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet 386(10001):1353–1361. doi:10.1016/S0140-6736(15)60908-4 CrossRef Early Breast Cancer Trialists’ Collaborative G, Coleman R, Powles T, Paterson A, Gnant M, Anderson S, Diel I, Gralow J, von Minckwitz G, Moebus V, Bergh J, Pritchard KI, Bliss J, Cameron D, Evans V, Pan H, Peto R, Bradley R, Gray R (2015) Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet 386(10001):1353–1361. doi:10.​1016/​S0140-6736(15)60908-4 CrossRef

go back to reference PAH Organisation (2016) Mammography services quality assurance: baseline standards for Latin America and the Caribbean. PAHO, Washington PAH Organisation (2016) Mammography services quality assurance: baseline standards for Latin America and the Caribbean. PAHO, Washington

go back to reference Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, Caffarella RS, Corbex M, Kreps GL, McTiernan A (2008) Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 113:2244–2256. doi:10.1002/cncr.23842 CrossRefPubMed Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, Caffarella RS, Corbex M, Kreps GL, McTiernan A (2008) Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 113:2244–2256. doi:10.​1002/​cncr.​23842 CrossRefPubMed

go back to reference Devi BC, Tang TS, Corbex M (2007) Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 18(7):1172–1176. doi:10.1093/annonc/mdm105 CrossRefPubMed Devi BC, Tang TS, Corbex M (2007) Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 18(7):1172–1176. doi:10.​1093/​annonc/​mdm105 CrossRefPubMed

go back to reference Corbex M, Burton R, Sancho-Garnier H (2012) Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast 21:428–434. doi:10.1016/j.breast.2012.01.002 CrossRefPubMed Corbex M, Burton R, Sancho-Garnier H (2012) Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast 21:428–434. doi:10.​1016/​j.​breast.​2012.​01.​002 CrossRefPubMed